Lineage, Inc. — Form 8-K Summary
Business Context and Reporting Period
Lineage, Inc. filed a Form 8-K dated September 22, 2026, with subsequent events described on September 23–24, 2026. The filing reports changes to the Board of Directors and the transition of the Chief Transformation Officer. It does not provide quarterly or annual financial results.
Key Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, margins, debt balances, liquidity measures, or other financial metrics. The company’s common stock trades under the symbol LINE, and its 4.125% Senior Notes due 2031 trade under LINE31 on Nasdaq.
Material Changes
- James Wyper resigned as a director effective immediately on September 22, 2026. The filing states that the resignation was not due to any disagreement with the company regarding operations, policies, or practices.
- Paul Beiboer was appointed to the Board effective September 23, 2026, to serve until the 2027 annual meeting or until his successor is elected and qualifies. He was also appointed to the Talent and Compensation Committee.
- The filing states that Mr. Beiboer has no appointment-related arrangements or understandings with other persons and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
- Sudarsan Thattai’s Chief Transformation Officer responsibilities will transition to other members of management effective September 28, 2026. He will cease to be an executive officer on that date and remain with the company as a Special Adviser through his planned retirement date of April 2, 2027.
Compensation, Outlook, and Risks
Under a Transition Agreement dated September 23, 2026, Mr. Thattai is expected to continue receiving substantially the same compensation and employee benefits through his retirement date while serving as Special Adviser. Mr. Beiboer will receive prorated compensation under the company’s Non-Employee Director Compensation Program and enter into the standard director indemnification agreement.
The filing provides no financial guidance, operating outlook, material contingencies, or new risk factors. It does not quantify the financial impact of the executive transition or director appointment.
Important Facts for Investors to Verify
- Confirm the effective dates of Mr. Wyper’s resignation, Mr. Beiboer’s appointment, and the September 28, 2026 executive-responsibility transition.
- Review the company’s subsequent filings for the identity of management assuming the Chief Transformation Officer responsibilities.
- Assess any future disclosure regarding the cost or terms of Mr. Thattai’s Transition Agreement.
- Review the company’s next periodic report for updated Board committee composition, executive-officer status, and financial results.